When sponsors talk about AI for clinical writing, the first promise they hear is speed. A first draft of a study report section in minutes instead of days. Narratives produced in bulk. It sounds like the answer to a problem every clinical team knows: documents that are always late.
But look closely at where the time goes on a clinical study report or a submission summary, and drafting is rarely the longest step. Review is. And a tool that makes drafting faster without making review easier can make the whole process slower.
Where the time really goes
A typical clinical document passes through several rounds of review: the writer's own check, a quality control check against source, review by clinical, statistics, safety and regulatory, and then resolution of all their comments. Each round finds things. Each fix needs checking. Late changes to data restart parts of the cycle.
The drafting itself is a fraction of that. Experienced writers can produce a good first draft quickly. What takes the time is making sure every number, every statement and every cross-reference is right, and agreeing the wording of anything that involves judgement.
How fast drafting can slow things down
If AI produces drafts faster, more drafts arrive at the review stage sooner. If reviewers cannot check them faster, the queue simply moves. Worse, AI drafts tend to be fluent and confident, which makes errors harder to spot. Reviewers either slow down to check more carefully, or they do not, and errors pass through to later stages where they are more expensive to fix.
Speed at the start, without help at the review stage, is a false economy.
What actually shortens the cycle
Three things make review faster without making it weaker.
First, source traceability. When every statement links to its source, the quality control check becomes a matter of clicking and comparing, not searching. Unsupported statements stand out.
Second, consistency checking across the document and across the submission. Many review comments are about inconsistencies: a number that differs between the text and a table, or between two documents. Software can find these before a human reviewer does.
Third, clear boundaries on judgement. If the tool drafts descriptive content and leaves interpretation to the writer, reviewers know where to focus their attention. If the tool drafts everything, they have to treat everything as suspect.
Measuring the right thing
Sponsors evaluating AI for clinical writing should measure end-to-end cycle time, not drafting time. How long from data availability to an approved document? How many review rounds? How many comments per round, and of what kind? How many errors reached a late stage?
Those numbers tell you whether a tool helps. Drafting speed alone tells you very little.
The opportunity
There is a real gain available here, but it sits in the review stage, which is less exciting to demonstrate than a draft appearing on screen. The tools and teams that focus on making review faster and more reliable will deliver documents sooner. The ones that focus only on drafting will produce more drafts, waiting in the same queue.
For the practical detail, see choosing a medical writing model.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.